Skip to main content
Clinical Trials/ITMCTR2100004591
ITMCTR2100004591RecruitingPhase 1

Effect of Qingre Huoxue Decoction on Clinical Outcome of Patients with Coronary Heart Disease after PCI: An Ambispective Cohort Study Based on Real-World Clinical Practice

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational study

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 1. Aged over 18 years;
  • 2. It meets the diagnostic criteria of coronary heart disease;
  • 3. Stents were implanted into the target vessels for the first time;
  • 4. It conforms to the definition of successful PCI operation;
  • 5. The patients voluntarily participated in this study, signed a written informed consent form, and were willing to cooperate with the follow-up.

Exclusion Criteria

  • 1. Coronary heart disease should exclude myocardial ischemia, injury and necrosis caused by non-coronary atherosclerosis;
  • 2. Those who died within 7 days after PCI;
  • 3. With severe hepatorenal insufficiency, ALT and AST were defined as >5 ULN, and the creatinine clearance rate was less than 30mL/min;
  • 4. Suffer from severe immunodeficiency diseases (such as HIV, etc.), malignant tumors, autoimmune diseases, severe cerebrovascular diseases, blood system diseases, etc., or other diseases that may significantly reduce life expectancy;
  • 5. Pregnant or lactating women, mentally ill;
  • 6. Those who did not take western medicine regularly after operation;
  • 7. Those who participated in any drug clinical trial within 1 month before operation.

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

Similar Trials